Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

Apollo Endosurgery Inc (APEN) Stock Forecast 2025 - AI Price Prediction & Analysis

Apollo Endosurgery Inc (APEN) AI Stock Price Forecast & Investment Analysis

Apollo Endosurgery Inc Stock Price Chart and Technical Analysis

Loading Apollo Endosurgery Inc interactive price chart and technical analysis...

Apollo Endosurgery Inc (APEN) - Comprehensive Stock Analysis & Investment Research

Deep dive into Apollo Endosurgery Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Apollo Endosurgery Inc, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Apollo Endosurgery Inc: Apollo Endosurgery Inc operates in the Manufacturing sector, making it an emerging small-cap investment.

Apollo Endosurgery Inc (Stock Symbol: APEN) is a leading company in the Manufacturing sector , specifically operating within the Biological Product (except Diagnostic) Manufacturing industry.

The organization employs approximately 202 professionals worldwide and operates under the strategic leadership of CEO Gary Atkinson.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Apollo Endosurgery Inc's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Apollo Endosurgery Inc: With $112M in annual revenue and -35.3% net margin, the company demonstrates developing profitability.

Annual Revenue: $112 million generating a -35.3% net profit margin .

Market Capitalization: $420 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -98.7% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Apollo Endosurgery Inc stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Apollo Endosurgery Inc: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Apollo Endosurgery Inc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Apollo Endosurgery Inc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Apollo Endosurgery Inc: Market positioning analysis based on available financial and operational metrics.

Apollo Endosurgery Inc strategically competes in the highly dynamic Biological Product (except Diagnostic) Manufacturing marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 37.6% gross margin, indicating strong pricing power and operational efficiency.

Apollo Endosurgery Inc (APEN) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Apollo Endosurgery Inc stock analysis.

Loading Apollo Endosurgery Inc comprehensive fundamental analysis and insider trading data...

Deep dive into Apollo Endosurgery Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Apollo Endosurgery Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Apollo Endosurgery Inc: With a P/E ratio of -9.88, the market sees the stock as potentially undervalued.

P/E Ratio -9.88x
P/B Ratio 12.88x
Market Cap $420M
EPS $-0.98
Book Value/Share $0.78
Revenue/Share $1.83
FCF/Share $-1.18
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Apollo Endosurgery Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Apollo Endosurgery Inc: An ROE of -98.7% indicates room for improvement in shareholder value creation.

ROE -98.7%
ROA -28.6%
ROIC -27.8%
Gross Margin 37.6%
Operating Margin -27.8%
Net Margin -35.3%
EBT Margin -42.9%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Apollo Endosurgery Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Apollo Endosurgery Inc: A current ratio of 7.78 indicates strong liquidity.

Current Ratio 7.78x
Quick Ratio 6.65x
D/E Ratio 0.97x
Financial Leverage 2.27x
Interest Coverage -2.5x
Working Capital $47M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Apollo Endosurgery Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Apollo Endosurgery Inc: Free cash flow of $-21M indicates cash challenges that need attention.

Operating Cash Flow $-19M
Free Cash Flow $-21M
Capital Spending $-2M
FCF/Sales -31.2%
CapEx/Sales 2.6%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Apollo Endosurgery Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Apollo Endosurgery Inc: An asset turnover of 0.66x suggests room for improvement in asset utilization.

Asset Turnover 0.66x
Receivables Turnover 6.4x
Inventory Turnover 2.4x
Fixed Assets Turnover 11.3x
Days Sales Outstanding 57 days
Days Inventory 150 days
Payables Period 69 days
Cash Conversion Cycle 138 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Apollo Endosurgery Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Apollo Endosurgery Inc: With annual revenue of $112M, Apollo Endosurgery Inc demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $112M
Operating Income $-31M
Net Income $-39M
R&D Expense $12M
SG&A Expense $72M
Cost of Goods Sold $34M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 87%
Cash & Short-term Investments 65%
Total Liabilities 56%
Short-term Debt 2%
Accounts Receivable 9%
Inventory 11%
Dividend & Shareholder Information
Shares Outstanding 42M
Growth Metrics (YoY)
EPS Growth -9.8%

Latest Apollo Endosurgery Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Apollo Endosurgery Inc (APEN) stock price and investment outlook.

Apollo Endosurgery Inc Competitors & Peer Analysis - Manufacturing Sector

Comparative analysis of Apollo Endosurgery Inc against industry peers and competitors in the Manufacturing sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - Apollo Endosurgery Inc Stock Forecast

How accurate are Apollo Endosurgery Inc stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for APEN predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Apollo Endosurgery Inc stock price forecasts?

Our analysis considers Apollo Endosurgery Inc's financial metrics, Manufacturing sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Apollo Endosurgery Inc a good investment in 2025?

Based on our AI analysis, Apollo Endosurgery Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Apollo Endosurgery Inc forecasts updated?

Apollo Endosurgery Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Apollo Endosurgery Inc Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Apollo Endosurgery Inc stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...